Jump to content

Meta-DOT

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Seppi333 (talk | contribs) at 01:16, 19 June 2018 (External links: clean up using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Meta-DOT
Names
IUPAC name
1-[2,4-dimethoxy-5-(methylsulfanyl)phenyl]propan-2-amine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C12H19NO2S/c1-8(13)5-9-6-12(16-4)11(15-3)7-10(9)14-2/h6-8H,5,13H2,1-4H3 checkY
    Key: BEMIKIUJWHLJTP-UHFFFAOYSA-N checkY
  • InChI=1/C12H19NO2S/c1-8(13)5-9-6-12(16-4)11(15-3)7-10(9)14-2/h6-8H,5,13H2,1-4H3
    Key: BEMIKIUJWHLJTP-UHFFFAOYAK
  • O(c1cc(OC)c(cc1SC)CC(N)C)C
Properties
C12H19NO2S
Molar mass 241.350 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Meta-DOT, or 5-methylthio-2,4-dimethoxyamphetamine, is a lesser-known psychedelic drug. It is similar in structure to TMA-2. Meta-DOT was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 35 mg, and the duration unknown. Meta-DOT produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of Meta-DOT.

See also

Template:PiHKAL